DLA Piper advised Iovance Biotherapeutics, Latham & Watkins advised the underwriters on the transaction.Iovance Biotherapeutics, Inc. (Iovance), a biotechnology company focused on innovating, developing and delivering…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
